41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
2307057
194118
2
Public Timelines
FAQ

jan 1, 2011 - HPTN 052 trial shows 96% reduced risk of onfection in serodiscordant couples. FDA approves Complera a second all-in- one combination tablet.

Added to timeline:

Date:

jan 1, 2011
Now
~ 15 years ago